Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer

Clinical trial NCT00640978 · TERMINATED

Trial details

NCT number: NCT00640978
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2008-03-01
Primary completion: 2010-03-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.